Perspectives of the management of COVID-19 infection in China

Nanshan Zhong (Guangzhou, China)

Source: Webinar 2020: Perspectives of the management of COVID-19 infection in China
Number: 0
Disease area: -

Webcast

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Nanshan Zhong (Guangzhou, China). Perspectives of the management of COVID-19 infection in China. Webinar 2020: Perspectives of the management of COVID-19 infection in China

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Inês Louro - 29.03.2020 21:47
Great lecture, thank you!

Valentina Moggi Zafferani - 27.03.2020 21:24
Excellent presentation thankyou !!!



Hanna-Khrystyna Kudla - 13.03.2020 15:39
Thank you!

Juan Bautista Galdiz Iturri - 06.03.2020 12:07
Excellent we have to learn about your experience

Elene Khurtsidze - 06.03.2020 10:44
Excellent presentation! Thank you !

João Carlos Winck - 05.03.2020 23:10
Great insights! Well done! Your experience should inspire every european government!


Khalid Hassan Ba-Msahell - 04.03.2020 16:39
Nice lecture
You must Login to comment this presentation.


Related content which might interest you:
Coronavirus disease: outbreak in China and globally
Source: Webinar 2020
Year: 2020

Interview on Coronavirus COVID-19 management experience in China
Source: Webinar 2020: Interview on Coronavirus COVID-19 management experience in China
Year: 2020

Diagnosis and treatment of COVID-19
Source: Webinar 2020: Diagnosis and treatment of COVID-19
Year: 2020

ERS/ATS joint webinar: Rehabilitation after COVID 19 disease
Source: ERS webinar 2020: ERS/ATS joint webinar: Rehabilitation after COVID 19 disease
Year: 2020


SARS-CoV-2 (COVID-19): Research response
Source: Webinar 2020: SARS-CoV-2 (COVID-19): research response
Year: 2020

ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment
Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment
Year: 2020

COVID-19: Q and A
Source: ERS Webinar 2020: COVID-19: Q and A
Year: 2020

ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme
Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme
Year: 2020

Health Policy of COVID-19 management
Source: ERS Webinar 2020: Health Policy of COVID-19 management
Year: 2020

Update on respiratory virus research and clinical care including influenza outbreak 2017-18, SARS, MERS and other respiratory pathogens
Source: International Congress 2018 – PG3 How to plan for and manage a respiratory epidemic/pandemic
Year: 2018


Human metapneumovirus, new agent of low respiratory infection, in infants hospitalized in Valparaiso, Chile
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009


Hot topics in COVID-19 in children
Source: ERS webinar 2020: Hot topics in COVID-19 in children
Year: 2020


Human metapneumovirus and community-acquired pneumonia: a pediatric survey
Source: Annual Congress 2005 - New insights in respiratory infections in children
Year: 2005


Effects of allergic diseases on SARS-CoV-2 infection: Chinese and European perspectives
Source: ERS webinar 2020: Effects of allergic diseases on SARS-CoV-2 infection: Chinese and European perspectives
Year: 2020

RSV and human metapneumovirus – major pathogens of childhood – also adults and the elderly?
Source: Annual Congress 2005 - Major viral threats to the lung
Year: 2005

How contagious are the new viruses and how can you protect yourself?
Source: Annual Congress 2005 - Major viral threats to the lung
Year: 2005

Human metapneumovirus in asthmatic children in South east Asia
Source: Annual Congress 2005 - New insights in respiratory infections in children
Year: 2005


A nosocomial outbreak of influenza during a period without influenza epidemic activity
Source: Eur Respir J 2003; 21: 303-307
Year: 2003



Historical perspective: other human coronavirus infectious diseases, SARS and MERS
Source: Eur Respir Monogr 2021; 94: 28-38
Year: 2021


Influenza type A outbreak associated with myositis
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005